| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Revenue: | ||||||||
Revenue | ||||||||
27,368 | 6,347 | 0 | 0 | 0 | - | - | - | - |
Operating expenses: | ||||||||
Research and development | ||||||||
38,281 | 34,216 | 29,067 | 25,299 | 22,090 | 19,787 | 0 | 0 | 0 |
General and administrative | ||||||||
11,542 | 9,613 | 7,814 | 6,117 | 4,269 | 3,409 | 0 | 0 | 0 |
Total operating expenses | ||||||||
49,823 | 43,829 | 36,881 | 31,416 | 26,359 | 23,196 | 0 | 0 | 0 |
Income (loss) from operations | ||||||||
-22,455 | -37,482 | -32,539 | -28,657 | -25,002 | -23,196 | 0 | 0 | 0 |
Other income, net | ||||||||
4,606 | 3,745 | 2,867 | 1,709 | 1,044 | 397 | 0 | 0 | 0 |
Net income (loss) | ||||||||
-17,849 | -33,737 | -29,672 | -26,948 | -23,958 | -22,799 | 0 | 0 | 0 |
Earnings (loss) per share | ||||||||
Basic (in dollars per share) | ||||||||
0.35 | - | - | - | -4.46 | - | - | - | - |
Diluted (in dollars per share) | ||||||||
0.33 | - | - | - | -4.46 | - | - | - | - |
Shares used in the calculation of earnings (loss) per share | ||||||||
Basic (in shares) | ||||||||
27,506 | - | - | - | 1,379 | - | - | - | - |
Diluted (in shares) | ||||||||
29,348 | - | - | - | 1,379 | - | - | - | - |
Net loss per common share—basic and diluted (in dollars per share) | ||||||||
- | - | -0.37 | -0.61 | - | -5.00 | -4.17 | -3.82 | -3.65 |
Weighted average number of common shares —basic and diluted (in shares) | ||||||||
- | - | 22,715 | 13,498 | - | 1,371 | 1,369 | 1,369 | 1,369 |
Comprehensive income (loss): | ||||||||
Net income (loss) | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Unrealized loss on marketable securities | ||||||||
0 | - | 0 | - | - | - | - | - | - |
Total comprehensive income (loss) | ||||||||
0 | - | 0 | - | 0 | - | 0 | - | - |